½ÃÀ庸°í¼­
»óǰÄÚµå
1672953

»öÀü¼ú ½ÃÀå : Á¦Ç° À¯Çüº°, ÀûÀÀÁõº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°

Embolization Market, By Product Type, By Indication, By End User, By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è »öÀü¼ú ½ÃÀåÀº 2025³â¿¡ 24¾ï ´Þ·¯, 2032³â¿¡´Â 42¾ï 8,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025-2032³â°£ ¿¬Æò±Õ 8.6%ÀÇ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ »ó¼¼ ³»¿ë
±âÁØ ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 24¾ï ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£(2025-2032³â) CAGR 8.60% 2032³â ±Ý¾× ¿¹Ãø 42¾ï 8,000¸¸ ´Þ·¯
±×¸². 2025³â Áö¿ªº° »öÀü¼ú ½ÃÀå Á¡À¯À²(%)
Embolization Market-IMG1

»öÀü¼úÀº Çϳª ¶Ç´Â ¿©·¯ °³ÀÇ µ¿¸ÆÀ̳ª Á¤¸ÆÀ» ¸·´Â ÃÖ¼Ò Ä§½ÀÀû ½Ã¼úÀÔ´Ï´Ù. ÀϹÝÀûÀ¸·Î Á¾¾ç, Ç÷°ü ±âÇü, µ¿¸Æ·ù µîÀÇ ÁúȯÀ» Ä¡·áÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. »öÀü¼úÀº Ä«Å×ÅͶó´Â °¡´À´Ù¶õ °üÀ» µ¿¸ÆÀ̳ª Á¤¸Æ¿¡ »ðÀÔÇÏ¿© ¼øÈ¯°è¸¦ ÅëÇØ Ç¥Àû ºÎÀ§±îÁö Åë°ú½Ãŵ´Ï´Ù. Ä¡·áÇÏ´Â º´Å¿¡ µû¶ó ¹Ú¸® °¡´ÉÇÑ ÄÚÀÏ, ¾ËÄÚ¿Ã, Á©¶óƾ ½ºÆÝÁö, ºñµå µîÀÇ »öÀü ¹°ÁúÀ» Ä«Å×Å͸¦ ÅëÇØ ÁÖÀÔÇÏ¿© Ç÷·ù¸¦ Â÷´ÜÇÕ´Ï´Ù. ÀÌ ÃÖ÷´Ü Ä¡·á¹ýÀº °³º¹ ¼ö¼úÀÇ ´ë¾ÈÀ¸·Î ÅëÁõ, ÈäÅÍ, ȸº¹ ½Ã°£, ºñ¿ëÀÌ Àû°Ô µå´Â ÀåÁ¡ÀÌ ÀÖ½À´Ï´Ù. »öÀü¼úÀº ´Ù¾çÇÑ Ä¡·á ¹× Áø´Ü¿¡ äÅõǰí ÀÖÀ¸¸ç, »öÀü¼ú ¼¼°è ½ÃÀå ¼ºÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ

¼¼°è »öÀü¼ú ½ÃÀåÀº ¾Ï, Ç÷°üÁúȯ, ¿Ü»ó µî ´Ù¾çÇÑ ´ë»ó ÁúȯÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ °ý¸ñÇÒ ¸¸ÇÑ ¼ºÀåÀ» º¸À̰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º´Å¿¡ Ãë¾àÇÑ ³ë³âÃþ Áõ°¡°¡ ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. »öÀü¼ú Ä¡·á ÀåºñÀÇ ±â¼úÀû Áøº¸, »ý¹°ÇÐÀû Ȱ¼º »öÀüÁ¦ÀÇ Ã¤ÅÃ, °³º¹ ¼ö¼úº¸´Ù ÃÖ¼Òħ½À ¼ö¼ú¿¡ ´ëÇÑ ¼±È£´Â ½ÃÀå ÁøÃâ±â¾÷¿¡°Ô À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ±×·¯³ª ½ÅÁ¦Ç° ½ÂÀο¡ ´ëÇÑ ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°Ç, ³ôÀº ºñ¿ë, ÀϺΠÁö¿ª¿¡¼­´Â ¼÷·ÃµÈ Àü¹®°¡ ºÎÁ·ÀÌ ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ½ÃÀå ÁøÃâ±â¾÷µéÀÌ »öÀü¼ú¿¡ ´ëÇÑ ÀνÄÀ» ³ôÀ̱â À§ÇÑ ´Ù¾çÇÑ ³ë·Â°ú ÷´Ü »öÀü¼ú Àç·áÀÇ °³¹ßÀº °¡±î¿î ½ÃÀÏ ³»¿¡ ÀÌ·¯ÇÑ Àå¾Ö¿äÀÎÀ» ±Øº¹ÇÏ´Â µ¥ µµ¿òÀÌ µÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

  • ¼¼°èÀÇ »öÀü¼ú ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇÏ¿© 2024³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2025-2032³â) ½ÃÀå ±Ô¸ð¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» Á¶»çÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
  • ¶ÇÇÑ, ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
  • ¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ °íÂûÀ» Á¦°øÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­´Â ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ¼º°ú, Àü·« µîÀÇ ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è »öÀü¼ú ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­ÀÇ ÅëÂû·ÂÀ» ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯Çü ¾÷±×·¹À̵å, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
  • ¼¼°è »öÀü¼ú ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ½ÃÀå ÁøÃâ±â¾÷, À繫 ºÐ¼®°¡ µî ÀÌ »ê¾÷ÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
  • ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è »öÀüÁõ ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú ÀüÁ¦Á¶°Ç

  • Á¶»ç ¸ñÀû
  • ÀüÁ¦Á¶°Ç
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à
  • Coherent Opportunity Map (COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
  • ¿µÇ⠺м®
  • ½ÃÀå µ¿Çâ
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • Àμö¿Í Á¦ÈÞ ½Ã³ª¸®¿À
  • ÀÚ±ÝÁ¶´Þ°ú ÅõÀÚ
  • PEST ºÐ¼®
  • PorterÀÇ Five Forces ºÐ¼®

Á¦4Àå ¼¼°èÀÇ »öÀü¼ú ½ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

  • ÀüüÀûÀÎ ¿µÇâ
  • Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê
  • ½ÃÀå¿¡ ´ëÇÑ COVID-19ÀÇ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ »öÀü¼ú ½ÃÀå, Á¦Ç° À¯Çüº°, 2020-2032³â(10¾ï ´Þ·¯)

  • ¼­·Ð
  • ÀÔÀÚ
  • ¹æ»ç¼± »öÀü¼ú ½ºÇǾî
  • ¾à¹° ¿ëÃâ ºñÁî
  • ¸¶ÀÌÅ©·Î½ºÇǾî(¶Ç´Â ¾àÁ¦¸¦ Æ÷ÇÔÇÏÁö ¾Ê´Â ºê·£µå ºñÁî)
  • PVA ÀÔÀÚ(Æú¸®ºñ´Ò ¾ËÄÚ¿Ã)
  • ¾×ü»öÀü
  • Ç÷¯±×
  • ÄÚÀÏ

Á¦6Àå ¼¼°èÀÇ »öÀü¼ú ½ÃÀå, ÀûÀÀÁõº°, 2020-2032³â(10¾ï ´Þ·¯)

  • ¼­·Ð
  • ÃâÇ÷
  • ¾ç¼º Àü¸³¼± ºñ´ëÁõ(BPH)
  • ÀڱñÙÁ¾
  • Á¾¾ç(¾Ç¼º Á¾¾ç, °£¾Ï Æ÷ÇÔ)
  • ±âÇü(AVM, AVF)
  • Á¤¸Æ »öÀü¼ú
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ »öÀü¼ú ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2020-2032³â(10¾ï ´Þ·¯)

  • ¼­·Ð
  • º´¿ø Ŭ¸®´Ð
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ »öÀü¼ú ½ÃÀå, Áö¿ªº°, 2020-2032³â(10¾ï ´Þ·¯)

  • ¼­·Ð
  • ºÏ¹Ì
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿
  • ¾ÆÇÁ¸®Ä«

Á¦9Àå °æÀï ±¸µµ

  • ±â¾÷ °³¿ä
    • Stryker Corporation
    • Medtronic plc
    • Boston Scientific Corporation
    • Johnson & Johnson(Cerenovis)
    • Terumo Corporation
    • Cook Medical
    • B. Braun Melsungen AG
    • Penumbra, Inc.
    • BTG plc
    • Merit Medical Systems
    • Pfizer Inc.
    • Abbott Laboratories
    • Acandis GmbH & Co. KG
    • Blockade Medical LLC
    • MicroPort Scientific Corporation
    • Kaneka Corporation
    • Galt Medical

Á¦10Àå ¾Ö³Î¸®½ºÆ® Ãßõ »çÇ×

  • À¶¼º°ú ¼èÅð
  • Coherent Opportunity Map

Á¦11Àå Âü°í ¹®Çå°ú Á¶»ç ¹æ¹ý

  • Âü°í ¹®Çå
  • Á¶»ç ¹æ¹ý
LSH 25.04.01

Global Embolization Market is estimated to be valued at USD 2.40 Bn in 2025 and is expected to reach USD 4.28 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.6% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 2.40 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 8.60% 2032 Value Projection: USD 4.28 Bn
Figure. Embolization Market Share (%), By Region 2025
Embolization Market - IMG1

Embolization is a minimally invasive procedure that blocks one or more arteries or veins. It is commonly used to treat medical conditions such as tumors, vascular malformations, and aneurysms. Embolization uses slender tubes called catheters, which are inserted into an artery or vein and then threaded through the circulatory system to the target site. Depending on the condition being treated, embolic materials such as detachable coils, alcohol, gelatin sponges, or beads are delivered through the catheter to block the blood flow. This cutting-edge therapy provides an alternative to open surgery and is associated with less pain, scarring, recovery time, and costs. Embolization is increasingly employed for various therapeutic and diagnostic procedures, thus, driving the global embolization market growth.

Market Dynamics:

Global embolization market is witnessing significant growth due to rising prevalence of various target conditions such as cancer, vascular diseases, and traumatic injuries. Growing geriatric population who are more prone to such conditions can drive the market growth. Technological advancements in embolization devices, introduction of bioactive embolization agents, and preference for minimally invasive procedures over open surgeries offers lucrative opportunities for market players. However, strict regulatory requirements for new product approval, high costs involved, and lack of skilled professionals in some regions can hamper the market growth. Various initiatives by market players to spread awareness about embolization therapy and development of advanced embolization materials can help overcome these restraints in the near future.

Key Features of the Study:

  • This report provides in-depth analysis of the global embolization market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global embolization market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Boston Scientific Corp, Terumo Corporation, Medtronic plc, Stryker Corporation, and Abbott Laboratories.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • Global embolization market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global embolization market.

Detailed Segmentation-

  • By Product Type:
    • Particles
    • Radioembolization Spheres
    • Drug-Eluting Bead
    • Microspheres (or Blands beads, without drug)
    • PVA Particles (Polyvinyl Alcohol)
    • Liquid Embolic
    • Plugs
    • Coils
  • By Indication
    • Hemorrhage/Bleeding
    • Benign Prostatic Hyperplasia (BPH)
    • Uterine Fibroid
    • Tumor (Malignant, including Liver Cancer)
    • Malformation (AVM, AVF)
    • Venous embolization
    • Others
  • By End User
    • Hospitals & Clinics
    • Ambulatory Surgical Centers
    • Others
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Stryker Corporation
    • Medtronic plc
    • Boston Scientific Corporation
    • Johnson & Johnson (Cerenovis)
    • Terumo Corporation
    • Cook Medical
    • Braun Melsungen AG
    • Penumbra, Inc.
    • BTG plc
    • Merit Medical Systems
    • Pfizer Inc.
    • Abbott Laboratories
    • Acandis GmbH & Co. KG
    • Blockade Medical LLC
    • MicroPort Scientific Corporation
    • Kaneka Corporation
    • Galt Medical

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product Type
    • Market Snapshot, By Indication
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Embolization Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Embolization Market, By Product Type, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Particles
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Radioembolization Spheres
  • Drug-Eluting Bead
  • Microspheres (or Blands beads, without drug)
  • PVA particles (Polyvinyl Alcohol)
  • Liquid Embolic
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Plugs
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Coils
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Embolization Market, By Indication, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Hemorrhage/Bleeding
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Benign Prostatic Hyperplasia (BPH)
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Uterine Fibroid
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Tumor (Malignant, including Liver Cancer)
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Malformation (AVM, AVF)
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Venous embolization
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Embolization Market, By End User, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Hospitals & Clinics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Ambulatory Surgical Centers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Embolization Market, By Region, 2020 - 2032, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profiles
    • Stryker Corporation
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Medtronic plc
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Boston Scientific Corporation
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Johnson & Johnson (Cerenovis)
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Terumo Corporation
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Cook Medical
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • B. Braun Melsungen AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Penumbra, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • BTG plc
    • Merit Medical Systems
    • Pfizer Inc.
    • Abbott Laboratories
    • Acandis GmbH & Co. KG
    • Blockade Medical LLC
    • MicroPort Scientific Corporation
    • Kaneka Corporation
    • Galt Medical

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦